Annual Current Assets
$1.61 B
+$153.50 M+10.56%
31 December 2023
Summary:
Neurocrine Biosciences annual total current assets is currently $1.61 billion, with the most recent change of +$153.50 million (+10.56%) on 31 December 2023. During the last 3 years, it has risen by +$634.20 million (+65.19%). NBIX annual current assets is now at all-time high.NBIX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$1.88 B
+$206.80 M+12.38%
30 September 2024
Summary:
Neurocrine Biosciences quarterly total current assets is currently $1.88 billion, with the most recent change of +$206.80 million (+12.38%) on 30 September 2024. Over the past year, it has increased by +$269.60 million (+16.78%). NBIX quarterly current assets is now at all-time high.NBIX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +16.8% |
| 3 y3 years | +65.2% | +92.9% |
| 5 y5 years | +93.4% | +125.8% |
NBIX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +65.2% | at high | +92.9% |
| 5 y | 5 years | at high | +117.8% | at high | +129.1% |
| alltime | all time | at high | +2801.4% | at high | +7751.9% |
Neurocrine Biosciences Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.88 B(+12.4%) |
| June 2024 | - | $1.67 B(-7.2%) |
| Mar 2024 | - | $1.80 B(+11.9%) |
| Dec 2023 | $1.64 B(+79.7%) | $1.61 B(-2.6%) |
| Sept 2023 | - | $1.65 B(+10.2%) |
| June 2023 | - | $1.50 B(+4.5%) |
| Mar 2023 | - | $1.43 B(-1.4%) |
| Dec 2022 | $915.20 M(-16.8%) | $1.45 B(+20.6%) |
| Sept 2022 | - | $1.21 B(+18.3%) |
| June 2022 | - | $1.02 B(+0.1%) |
| Mar 2022 | - | $1.02 B(+4.7%) |
| Dec 2021 | $1.10 B(+53.1%) | $972.80 M(-3.3%) |
| Sept 2021 | - | $1.01 B(-9.4%) |
| June 2021 | - | $1.11 B(+2.3%) |
| Mar 2021 | - | $1.09 B(+6.8%) |
| Dec 2020 | $718.50 M(+51.3%) | $1.02 B(-12.2%) |
| Sept 2020 | - | $1.16 B(+0.9%) |
| June 2020 | - | $1.15 B(+18.4%) |
| Mar 2020 | - | $968.20 M(+16.5%) |
| Dec 2019 | $475.00 M(+86.0%) | $831.00 M(+1.4%) |
| Sept 2019 | - | $819.23 M(+9.4%) |
| June 2019 | - | $748.81 M(+18.3%) |
| Mar 2019 | - | $633.19 M(-14.2%) |
| Dec 2018 | $255.37 M(-2.8%) | $737.78 M(+3.3%) |
| Sept 2018 | - | $714.39 M(+25.8%) |
| June 2018 | - | $567.68 M(+10.5%) |
| Mar 2018 | - | $513.72 M(-7.4%) |
| Dec 2017 | $262.67 M(+380.7%) | $554.92 M(+1.2%) |
| Sept 2017 | - | $548.49 M(+2.2%) |
| June 2017 | - | $536.75 M(+124.2%) |
| Mar 2017 | - | $239.45 M(-22.9%) |
| Dec 2016 | $54.64 M(-39.8%) | $310.44 M(-13.3%) |
| Sept 2016 | - | $357.89 M(-8.7%) |
| June 2016 | - | $391.97 M(-2.2%) |
| Mar 2016 | - | $400.98 M(+4.4%) |
| Dec 2015 | $90.71 M(+102.3%) | $384.07 M(+0.3%) |
| Sept 2015 | - | $382.79 M(-1.7%) |
| June 2015 | - | $389.42 M(-3.8%) |
| Mar 2015 | - | $404.95 M(+104.3%) |
| Dec 2014 | $44.83 M(+621.4%) | $198.20 M(+7.8%) |
| Sept 2014 | - | $183.87 M(-6.9%) |
| June 2014 | - | $197.57 M(-10.9%) |
| Mar 2014 | - | $221.74 M(+49.4%) |
| Dec 2013 | $6.21 M(-7.5%) | $148.46 M(-6.8%) |
| Sept 2013 | - | $159.22 M(+2.2%) |
| June 2013 | - | $155.85 M(-2.8%) |
| Mar 2013 | - | $160.40 M(-15.3%) |
| Dec 2012 | $6.71 M(+14.0%) | $189.26 M(+6.3%) |
| Sept 2012 | - | $178.02 M(-1.8%) |
| June 2012 | - | $181.26 M(-2.0%) |
| Mar 2012 | - | $184.97 M(+39.6%) |
| Dec 2011 | $5.89 M(-48.2%) | $132.48 M(-2.7%) |
| Sept 2011 | - | $136.13 M(+13.4%) |
| June 2011 | - | $120.04 M(-5.2%) |
| Mar 2011 | - | $126.58 M(-4.9%) |
| Dec 2010 | $11.37 M | $133.05 M(+1.1%) |
| Sept 2010 | - | $131.59 M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $143.76 M(+110.4%) |
| Mar 2010 | - | $68.33 M(+23.4%) |
| Dec 2009 | $15.43 M(-58.0%) | $55.39 M(-4.8%) |
| Sept 2009 | - | $58.19 M(+8.2%) |
| June 2009 | - | $53.78 M(-20.0%) |
| Mar 2009 | - | $67.20 M(-17.5%) |
| Dec 2008 | $36.76 M(-60.8%) | $81.42 M(-17.6%) |
| Sept 2008 | - | $98.81 M(-13.0%) |
| June 2008 | - | $113.63 M(-25.3%) |
| Mar 2008 | - | $152.20 M(-16.8%) |
| Dec 2007 | $93.71 M(-52.2%) | $182.95 M(+42.7%) |
| Sept 2007 | - | $128.18 M(-14.9%) |
| June 2007 | - | $150.59 M(-11.6%) |
| Mar 2007 | - | $170.31 M(-12.1%) |
| Dec 2006 | $196.02 M(-3.8%) | $193.66 M(-5.4%) |
| Sept 2006 | - | $204.78 M(-14.9%) |
| June 2006 | - | $240.63 M(-12.4%) |
| Mar 2006 | - | $274.72 M(-1.6%) |
| Dec 2005 | $203.81 M(-0.8%) | $279.31 M(-6.2%) |
| Sept 2005 | - | $297.63 M(+9.6%) |
| June 2005 | - | $271.52 M(-3.4%) |
| Mar 2005 | - | $281.03 M(-10.4%) |
| Dec 2004 | $205.40 M(+147.0%) | $313.81 M(-6.8%) |
| Sept 2004 | - | $336.66 M(+0.2%) |
| June 2004 | - | $336.05 M(-11.9%) |
| Mar 2004 | - | $381.65 M(-19.1%) |
| Dec 2003 | $83.15 M(+350.8%) | $471.81 M(+1.6%) |
| Sept 2003 | - | $464.37 M(+47.7%) |
| June 2003 | - | $314.30 M(-8.0%) |
| Mar 2003 | - | $341.81 M(+37.8%) |
| Dec 2002 | $18.45 M(+24.3%) | $248.09 M(-11.7%) |
| Sept 2002 | - | $281.12 M(-4.6%) |
| June 2002 | - | $294.60 M(-6.1%) |
| Mar 2002 | - | $313.61 M(-5.4%) |
| Dec 2001 | $14.84 M(+9.4%) | $331.51 M(+103.8%) |
| Sept 2001 | - | $162.67 M(+9.3%) |
| June 2001 | - | $148.84 M(-6.3%) |
| Mar 2001 | - | $158.88 M(-7.8%) |
| Dec 2000 | $13.56 M(-5.9%) | $172.41 M(+108.7%) |
| Sept 2000 | - | $82.62 M(-0.6%) |
| June 2000 | - | $83.10 M(-9.7%) |
| Mar 2000 | - | $92.02 M(-2.9%) |
| Dec 1999 | $14.40 M(-3.4%) | $94.80 M(+74.9%) |
| Sept 1999 | - | $54.20 M(-4.1%) |
| June 1999 | - | $56.50 M(-6.5%) |
| Mar 1999 | - | $60.40 M(-7.9%) |
| Dec 1998 | $14.90 M(-3.9%) | $65.60 M(-3.4%) |
| Sept 1998 | - | $67.90 M(+2.1%) |
| June 1998 | - | $66.50 M(-9.0%) |
| Mar 1998 | - | $73.10 M(-4.3%) |
| Dec 1997 | $15.50 M(+162.7%) | $76.40 M(+3.9%) |
| Sept 1997 | - | $73.50 M(+1.2%) |
| June 1997 | - | $72.60 M(-4.8%) |
| Mar 1997 | - | $76.30 M(+5.8%) |
| Dec 1996 | $5.90 M | $72.10 M(+8.7%) |
| Sept 1996 | - | $66.30 M(-3.1%) |
| June 1996 | - | $68.40 M(+186.2%) |
| Mar 1996 | - | $23.90 M |
FAQ
- What is Neurocrine Biosciences annual total current assets?
- What is the all time high annual current assets for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly total current assets?
- What is the all time high quarterly current assets for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly current assets year-on-year change?
What is Neurocrine Biosciences annual total current assets?
The current annual current assets of NBIX is $1.61 B
What is the all time high annual current assets for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual total current assets is $1.61 B
What is Neurocrine Biosciences quarterly total current assets?
The current quarterly current assets of NBIX is $1.88 B
What is the all time high quarterly current assets for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly total current assets is $1.88 B
What is Neurocrine Biosciences quarterly current assets year-on-year change?
Over the past year, NBIX quarterly total current assets has changed by +$269.60 M (+16.78%)